Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 11, Issue 2, Pages 358-376
Publisher
Informa UK Limited
Online
2015-01-27
DOI
10.4161/21645515.2014.987014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations
- (2011) Angelika Banzhoff et al. Human vaccines & immunotherapeutics
- Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children
- (2011) Steven Black et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis
- (2011) F. Alghisi et al. THORAX
- Immunogenicity and safety of inactivated influenza vaccines in primed populations: A systematic literature review and meta-analysis
- (2011) W.E.P. Beyer et al. VACCINE
- Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents
- (2011) Susanna Esposito et al. VACCINE
- Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals
- (2010) Anna Kajaste-Rudnitski et al. AIDS
- MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk
- (2010) Paolo Durando et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- MF59™ as a vaccine adjuvant: a review of safety and immunogenicity
- (2010) Hana El Sahly Expert Review of Vaccines
- Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study
- (2010) Nabihah Sachedina et al. LANCET
- Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
- (2010) Elizabeth Miller et al. LANCET
- An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients
- (2010) S. Esposito et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to
- (2010) Chi-Eun Oh et al. VACCINE
- Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major
- (2010) Susanna Esposito et al. VACCINE
- Strategies for Pandemic and Seasonal Influenza Vaccination of Schoolchildren in the United States
- (2009) N. E. Basta et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
- (2009) Eric Plennevaux et al. LANCET
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
- (2009) Tristan W. Clark et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
- (2009) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus
- (2009) Y. Yang et al. SCIENCE
- Optimizing Influenza Vaccine Distribution
- (2009) J. Medlock et al. SCIENCE
- MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
- (2009) Michele Pellegrini et al. VACCINE
- Exposure to MF59-adjuvanted influenza vaccines during pregnancy—A retrospective analysis
- (2009) Theodore Tsai et al. VACCINE
- MF59® -adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
- (2008) Angelika Banzhoff et al. Influenza and Other Respiratory Viruses
- Safety of MF59™ adjuvant
- (2008) Viola Schultze et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More